"The fear of higher rates in the near term played havoc on the front end of the curve, and the market wasn't ready for that," Sean Simko, a money manager who oversees US$10 billion at SEI Investments in Oaks, Pennsylvania, told Bloomberg News.
Last week, the Standard & Poor's 500 index fell 0.5 per cent and the Nasdaq Composite index dropped 2.8 per cent as investors sold shares of internet and biotech companies to lock in profits. The Nasdaq Biotechnology Index sank 7 per cent last week. The Dow Jones Industrial Average rose 0.1 per cent.
So far in 2014, the Dow is down 1 per cent, while the Nasdaq has slid 0.2 per cent. The S&P has gained 1 per cent.
Europe's Stoxx 600 added 1.8 per cent last week, as did France's CAC 40. The UK's FTSE 100 gained 0.9 per cent, while Germany's DAX climbed 2.6 per cent.
Policy makers of the European Central Bank meet this week and are expected to keep the benchmark interest rate at a record low on Thursday.
On Friday, a report showed that economic confidence in the euro zone rose more than expected in March, helping to bolster optimism about the outlook and the sentiment for equities.
Data to watch here in the coming days include the euro-zone consumer price index, due today; euro-zone unemployment and manufacturing, due on Tuesday; euro-zone retail sales, due on Thursday; and German factory orders, due on Friday.
Among the latest clues for China's economy is the official March manufacturing purchasing managers' index, which will be released on Tuesday. There's also rising expectation that the Chinese government will detail measures to further contain the slowdown in the world's second-biggest economy, perhaps cutting interest rates.
On Wednesday, International Monetary Fund Managing Director Christine Lagarde will discuss the state of the global economy at Johns Hopkins University in Washington ahead of the 2014 IMF/World Bank spring meetings